CA1134825A - Substituted trans-3-(4-oxo-4h-quinazolin-3- yl)-2-propenoic acid derivatives - Google Patents

Substituted trans-3-(4-oxo-4h-quinazolin-3- yl)-2-propenoic acid derivatives

Info

Publication number
CA1134825A
CA1134825A CA000355555A CA355555A CA1134825A CA 1134825 A CA1134825 A CA 1134825A CA 000355555 A CA000355555 A CA 000355555A CA 355555 A CA355555 A CA 355555A CA 1134825 A CA1134825 A CA 1134825A
Authority
CA
Canada
Prior art keywords
alkyl
oxo
trans
quinazolin
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000355555A
Other languages
English (en)
French (fr)
Inventor
Ronald A. Lemahieu
William C. Nason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1134825A publication Critical patent/CA1134825A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000355555A 1979-07-09 1980-07-07 Substituted trans-3-(4-oxo-4h-quinazolin-3- yl)-2-propenoic acid derivatives Expired CA1134825A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5572879A 1979-07-09 1979-07-09
US55,728 1979-07-09
US06/142,903 US4281127A (en) 1979-07-09 1980-04-23 Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives
US142,903 1980-04-23

Publications (1)

Publication Number Publication Date
CA1134825A true CA1134825A (en) 1982-11-02

Family

ID=26734565

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000355555A Expired CA1134825A (en) 1979-07-09 1980-07-07 Substituted trans-3-(4-oxo-4h-quinazolin-3- yl)-2-propenoic acid derivatives

Country Status (21)

Country Link
US (1) US4281127A (enExample)
EP (1) EP0023594B1 (enExample)
AR (1) AR226854A1 (enExample)
AU (1) AU521014B2 (enExample)
CA (1) CA1134825A (enExample)
DE (1) DE3067830D1 (enExample)
DK (1) DK150483C (enExample)
ES (2) ES493203A0 (enExample)
FI (1) FI74279C (enExample)
GR (1) GR65952B (enExample)
HK (1) HK52187A (enExample)
HU (1) HU184797B (enExample)
IE (1) IE49938B1 (enExample)
IL (1) IL60514A (enExample)
MC (1) MC1333A1 (enExample)
NO (1) NO154426C (enExample)
NZ (1) NZ194259A (enExample)
PH (1) PH16413A (enExample)
PT (1) PT71512B (enExample)
SG (1) SG20887G (enExample)
YU (1) YU42348B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599336A (en) * 1983-08-08 1986-07-08 Hoffmann-La Roche Inc. Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
US6706721B1 (en) * 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US7087613B2 (en) * 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
JP2005529076A (ja) * 2002-02-15 2005-09-29 サイトキネティクス・インコーポレーテッド キナゾリノンの合成
AU2003223786A1 (en) * 2002-05-09 2003-11-11 Cytokinetics, Inc. Compounds, methods and compositions
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JP2005538062A (ja) * 2002-06-14 2005-12-15 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
JP2006501201A (ja) * 2002-07-23 2006-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
JP2005536553A (ja) * 2002-08-21 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
JP2006501306A (ja) * 2002-09-30 2006-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
UY29198A1 (es) * 2004-11-09 2006-05-31 Cancer Rec Tech Ltd Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786055A (en) * 1955-02-10 1957-03-19 Mallinckrodt Chemical Works Carboxyalkyl-iodoquinazolones
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones

Also Published As

Publication number Publication date
NZ194259A (en) 1984-09-28
HK52187A (en) 1987-07-17
HU184797B (en) 1984-10-29
IE801412L (en) 1981-01-09
IL60514A (en) 1985-03-31
EP0023594A1 (de) 1981-02-11
ES8106302A1 (es) 1981-05-16
PT71512A (en) 1980-08-01
PT71512B (en) 1981-12-11
ES493203A0 (es) 1981-05-16
GR65952B (enExample) 1981-01-09
YU176680A (en) 1984-12-31
ES8207155A1 (es) 1982-09-16
US4281127A (en) 1981-07-28
YU42348B (en) 1988-08-31
DE3067830D1 (en) 1984-06-20
AU6024480A (en) 1981-03-12
PH16413A (en) 1983-09-29
NO154426C (no) 1986-09-17
FI802195A7 (fi) 1981-01-10
ES499035A0 (es) 1982-09-16
NO802056L (no) 1981-01-12
IL60514A0 (en) 1980-09-16
FI74279C (fi) 1988-01-11
AR226854A1 (es) 1982-08-31
SG20887G (en) 1988-09-16
AU521014B2 (en) 1982-03-11
DK294780A (da) 1981-01-10
NO154426B (no) 1986-06-09
FI74279B (fi) 1987-09-30
DK150483C (da) 1987-11-09
IE49938B1 (en) 1986-01-08
MC1333A1 (fr) 1981-04-21
EP0023594B1 (de) 1984-05-16
DK150483B (da) 1987-03-09

Similar Documents

Publication Publication Date Title
CA1134825A (en) Substituted trans-3-(4-oxo-4h-quinazolin-3- yl)-2-propenoic acid derivatives
US5155110A (en) Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
EP0693478B1 (en) Quinoline compounds
JPS63146871A (ja) ベンゾイミダゾ−ル誘導体
JPH0853454A (ja) 薬理活性を有するピロロピリミジン
JP2003523335A (ja) Ｌｄｌ−ｐｌａ２阻害剤としてのピリミジン−４−オン誘導体
DE3834204A1 (de) 4h-1-benzopyran-4-on-derivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische mittel mit einem gehalt derselben als wirkstoff
US4188486A (en) 2-Substituted benzimidazole compounds
EP0398179B1 (en) Rhodanine derivatives and pharmaceutical compositions
US4435407A (en) Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
US4168380A (en) 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
CA1122216A (en) 7-methylthio or methylsulfinyl-5-oxo-5h-thiazolo- [2,3-b] quinazoline-2-carboxylic acid
US4192880A (en) 2-Substituted benzimidazole compounds
JP2003231633A (ja) 医薬組成物
EP0405442A1 (en) 4,5-Dihydro-6H-imidazo[4,5,1-ij]quinolin-6-one-6-oxime-O-sulfonic acid derivatives
KR960012367B1 (ko) 2-알킬설피닐-4(3h)-퀴나졸리논 유도체, 이의 제조방법 및 약제학적 조성물
US4348403A (en) 2-Amino-4-(4-benzyloxyphenyl)thiazoles, and their use in hyperlipemia
US4361579A (en) Organogermanium compounds
JPH01261387A (ja) 新規なキノキサリン誘導体及びそれを含有する坑潰瘍剤
JPH05246994A (ja) キノリルメトキシフエニル−アセトアミド類
US4609660A (en) Substituted carboxy-thiazolo[3,2-a]pyrimidine derivatives
KR840002243B1 (ko) 트랜스-3-(4-옥소-4h-퀴나졸린-3-일)-2-프로페노산 유도체의 제조방법
KR0168979B1 (ko) 티아졸릴 트리아졸로티아졸 유도체
JP4463900B2 (ja) フェニルアゾール化合物、製造法及び抗高脂血症薬
CA1189078A (en) Process for producing 4-oximino-1,2,3,4- tetrahydroquinoline derivatives and said derivatives produced thereby

Legal Events

Date Code Title Description
MKEX Expiry